摘要
目的构建带Flag标签pcDNA3.0载体的Sirt4真核表达载体,同时验证该基因与肝癌细胞HepG2生长之间的关系。方法以人卵巢文库为模板,采用PCR技术扩增出Sirt4的CDS区编码序列,将PCR产物插入到带Flag标签的pcDNA3.0载体上,转化大肠杆菌DH5α感受态细胞提取质粒,测序正确后将pcDNA3.0-Flag和pcDNA3.0-Flag-Sirt4分别转染肝癌细胞HepG2,Western印迹实验鉴定目的基因蛋白表达,CCK-8法、克隆形成实验测定其对肝癌细胞HepG2生长的影响,Transwell证明Sirt4对肝癌细胞HepG2体外侵袭能力的影响。结果双酶切结果显示,pcDNA3.0-Flag-Sirt4真核表达载体构建成功;Western印迹实验验证该基因蛋白成功表达;CCK-8法和克隆形成实验证明过表达Sirt4基因抑制HepG2细胞增殖,Transwell证明过表达Sirt4明显抑制HepG2细胞体外侵袭能力。结论pcDNA3.0-Flag-Sirt4真核表达载体构建成功,过表达Sirt4基因可抑制肝癌细胞增殖及体外侵袭能力,为进一步研究Sirt4在肝癌中的发生与发展奠定了基础。
Objective To construct the eukaryotic expression vector of Flag tagged pcDNA3.0 vector Sirt4 while verifying the effect of overexpression of the gene on proliferation in hepatocellular carcinoma HepG2 cells.Methods The CDS region coding sequence of Sirt4 was amplified from the human ovarian library using polymerase chain reaction (PCR) technique.Flag tagged pcDNA3.0 vector was inserted into the PCR product by double digestion.The plasmid was transformed into DH-5alpha for extraction.After sequencing was correct,pcDNA3.0-Flag and pcDNA3.0-Flag-Sirt4 were transfected into HepG2 cells respectively.Western blotting was used to identify the expression of the target gene protein.CCK-8 assay and clony formation assay were used to determine the effect of Sirt4 on the growth of HepG2 cells.Transwell demonstrated the effect of Sirt4 on the invasion ability of HepG2 cells in vitro.Results The results of double digestion showed that pcDNA3.0-Flag-Sirt4 eukaryotic expression vector was successfully constructed.Western blotting confirmed the successful expression of the gene protein.CCK-8 method and clone formation experiments proved that overexpression of pcDNA3.0-Flag-Sirt4 inhibited the proliferation of HepG2 cells.Transwell suggested that overexpression of pcDNA3.0-Flag-Sirt4 suppressed the invasion ability of HepG2 cells in vitro.Conclusion The successful construction of pcDNA3.0-Flag-Sirt4 eukaryotic expression vector proves that it can promote the proliferation of hepatocellular carcinoma (HCC) cells,which can contribute to further study of the occurrence and development of Sirt4 in HCC.
作者
朱祥
马晓燕
马路园
张德宇
刘娟
杨旭辉
赵彩彦
徐小洁
ZHU Xiang;MA Xiao-yan;MA Lu-yuan;ZHANG De-yu;LIU Juan;YANGXu-hui;ZHAO Cai-yan;XUXiao-jie(Department of Medical Molecular Biology,Institute of Biotechnology,Academy of Military Medical Sciences,Academy of Military Sciences,Beijing 100850,China;Department of Cardiovascular Disease,School of Chinese Medicine,Changchun University of Chinese Medicine,Changchun 130021,China;Department of Infectious Diseases,the Third Affiliated Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处
《军事医学》
CAS
北大核心
2019年第1期37-41,共5页
Military Medical Sciences
基金
国家自然科学基金面上项目(81672602)
国家自然科学基金优秀青年科学基金项目(81822037)
全军后勤科研计划重点项目(BWS16J010)